Report an error

Spotted something inaccurate in “MPO Inhibitor Mitiperstat Fails to Improve HFpEF Outcomes in Phase 2b Trial”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.